Print

Print


We stick to the IFCC reference method and the corresponding limits of 34 and 45 IU/L for F/M

 

See http://www.ncbi.nlm.nih.gov/pubmed/12241021  and http://www.ncbi.nlm.nih.gov/pubmed/12482620

 

Best regards, Bart

 

 B.E.P.B. Ballieux PhD, Clinical Biochemist Endocrinology, Department KCL, E2-P.  Leiden University Medical Centre, P.O.box 9600, 2300RC  Leiden
Tel: +3171-5262165/62278 Fax: +3171-5266753  email: [log in to unmask]
P Please consider the environment before printing this e-mail

 

 

 

 

 

Van: Clinical biochemistry discussion list [mailto:[log in to unmask]] Namens Jordaan Marieke
Verzonden: dinsdag 13 oktober 2015 14:28
Aan: [log in to unmask]
Onderwerp: ALT reference ranges

 

Dear colleagues

 

It would be interesting to get an impression of the ALT reference range used in other laboratories.

 

NICE CG165 on Diagnosis and Management of Chronic Hepatitis B, published in June 2013 (http://www.nice.org.uk/guidance/cg165/evidence/cg165-hepatitis-b-chronic-full-guideline3) makes reference to ALT a number of times, and bases important clinical decisions on “normal”, “abnormal” and “normalized” ALT levels, which they define as greater than or equal to 30 IU/L for males and greater than or equal to 19 IU/L for females

 

There is some explanation of why these cutoffs were chosen on page 159:

 

With alcohol use and obesity now so common the impact of using these ALT reference ranges on diagnostic investigations could be very significant.

 

Harmony does not appear to have agreed a cutoff for ALT, unlike other LFT.

 

If you want to reply with your cutoff only, I will collate the responses for the mailbase.

 

 

 

Regards

 

Marieke

 

Dr Marieke Jordaan

 

Consultant Chemical Pathologist

Mid-Yorkshire Trust

 

Email: [log in to unmask]

Tel: (01924) 317060 or ext 57060

PA, Diane Blakeston: (01924) 317056 or ext 57056

 

 

This e mail or any attachments to it may contain legally privileged or confidential data. You should not forward it to anyone without reference to the Trusts Confidentiality and E Mail policies for guidance.

If you are not the intended recipient, please notify the author immediately by telephone or by replying to this e-mail and then delete all copies of the e-mail on your system. If you are not the intended recipient, you must not use, disclose, distribute, copy, print or rely on this e-mail.

 

This email or any attachments to it may contain legally privileged or confidential data. You should not forward it to anyone without reference to the Trusts Confidentiality and EMail policies for guidance. If you are not the intended recipient, please notify the author immediately by telephone or by replying to this e-mail and then delete all copies of the e-mail on your system. If you are not the intended recipient, you must not use, disclose, distribute, copy, print or rely on this e-mail.

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/